Immunotherapy trials in mesothelioma - promising results, but don't stop here
Nat Rev Clin Oncol
.
2019 Dec;16(12):726-728.
doi: 10.1038/s41571-019-0291-4.
Authors
Anna K Nowak
1
2
3
,
Patrick M Forde
4
Affiliations
1
National Centre for Asbestos Related Diseases, University of Western Australia, Crawley, Western Australia, Australia. anna.nowak@uwa.edu.au.
2
Medical School, University of Western Australia, Crawley, Western Australia, Australia. anna.nowak@uwa.edu.au.
3
Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. anna.nowak@uwa.edu.au.
4
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
PMID:
31624358
DOI:
10.1038/s41571-019-0291-4
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Immunotherapy
Lung Neoplasms*
Mesothelioma*